{"nct_id":"NCT06469281","title":"A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-08-06","start_date_type":"ACTUAL","primary_completion_date":"2030-05-27","primary_completion_date_type":"ESTIMATED","completion_date":"2030-05-27","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["REGN"]}